Cimetidine 200mg/5ml oral solution sugar free

Страна: Велика Британія

мова: англійська

Джерело: MHRA (Medicines & Healthcare Products Regulatory Agency)

Активний інгредієнт:

Cimetidine

Доступна з:

Rosemont Pharmaceuticals Ltd

Код атс:

A02BA01

ІПН (Міжнародна Ім'я):

Cimetidine

Дозування:

40mg/1ml

Фармацевтична форма:

Oral solution

Адміністрація маршрут:

Oral

Клас:

No Controlled Drug Status

Тип рецепту:

Valid as a prescribable product

Огляд продуктів:

BNF: 01030100; GTIN: 5016119171390

інформаційний буклет

CIMETIDINE 200MG/5ML ORAL SOLUTION
n
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE
n
Keep this leaflet. You may need to read it again
n
If you have any further questions, ask your doctor or pharmacist
n
This medicine has been prescribed for you. Do not pass it on to
others. It may harm them, even if their symptoms are the same as yours
n
If any of the side effects gets serious, or if you notice any side
effects not listed in this leaflet, please tell your doctor or
pharmacist.
IN THIS LEAFLET:
1. What is Cimetidine Oral Solution and what is it used for
2. Before you take Cimetidine Oral Solution
3. How to take Cimetidine Oral Solution
4. Possible side effects
5. How to store Cimetidine Oral Solution
6. Further information
PATIENT INFORMATION LEAFLET
_Continued overleaf_
TELL YOUR DOCTOR IF YOU GET ANY OF THESE SIDE EFFECTS:
n
diarrhoea
n
feeling tired
n
breast swelling in men and impotence
n
headache, fever and dizziness
n
hallucinations (seeing or hearing things that are not there)
n
hair loss
n
skin rash
n
joint or muscle pain.
If any of the side effects get serious, or if you notice any side
effects not listed
in this leaflet, please tell your doctor or pharmacist.
5. HOW TO STORE CIMETIDINE ORAL SOLUTION
n
Keep out of the reach and sight of children
n
Do not store above 25°C and keep out of direct sunlight
n
Do not use 1 month from the date you first open it
n
Do not use after the expiry date which is stated on the label and
carton (exp: month, year)
n
The expiry date refers to the last day of that month
n
Do not use Cimetidine Oral Solution if you notice that the appearance
or smell of your medicine
has changed. Talk to your pharmacist
n
Medicines should not be disposed of via wastewater or household waste.
Ask your pharmacist
how to dispose of medicines no longer required. These measures will
help to protect the
environment.
6. FURTHER INFORMATION
WHAT CIMETIDINE ORAL SOLUTION CONTAINS
n
The active ingredient is cimetidine
n
The other ingredients are methyl hydroxybenzoate (E218)

Характеристики продукта

OBJECT 1
CIMETIDINE 200MG/5ML ORAL SOLUTION
Summary of Product Characteristics Updated 14-Jun-2013 | Rosemont
Pharmaceuticals Limited
1. Name of the medicinal product
Cimetidine 200mg/5ml Oral Solution
2. Qualitative and quantitative composition
Cimetidine 200mg/5ml
For excipients see 6.1.
3. Pharmaceutical form
Oral Solution
Clear yellow/orange colour with odour of peppermint and peach
4. Clinical particulars
4.1 Therapeutic indications
Cimetidine is indicated in the treatment of duodenal and benign
gastric ulceration, including that
associated with non-steroidal anti-inflammatory agents, recurrent and
stomal ulceration, oesophageal
reflux disease and other conditions where reduction of gastric acid by
cimetidine has been shown to be
beneficial: persistent, dyspeptic symptoms with or without ulceration,
particularly meal-related upper
abdominal pain, including such symptoms associated with non-steroidal
anti-inflammatory agents; the
prophylaxis of gastro-intestinal haemorrhage from stress ulceration in
seriously ill patients; before general
anaesthesia in patients thought to be at risk of acid aspiration
(Mendelson's) syndrome, particularly
obstetric patients during labour; to reduce malabsorption and fluid
loss in the short bowel syndrome; and
in pancreatic insufficiency to reduce degradation of enzyme
supplements. Cimetidine is also
recommended in the management of the Zollinger-Ellison syndrome.
4.2 Posology and method of administration
For oral administration only.
The total daily dose should not exceed 2.4g. Dosage should be reduced
in patients with impaired renal
function (_see Special warnings and precautions for use)_
Adults: For patients with _duodenal or benign gastric ulceration_, a
single daily dose of 800mg at bedtime
is recommended. Otherwise the usual dosage is 400mg twice a day with
breakfast and at bedtime. Other
effective regimens are 200mg three times a day with meals and 400mg at
bedtime (1.0g/day) and, if
inadequate, 400mg four times a day (1.6g/day) also with meals and at
bedtime.
Treatment